A new review including over 100 clinical trials has found that 13 common methods for medically inducing labor are similarly effective, but their safety profiles differ according to clinical context.

A new review including over 100 clinical trials has found that no induction method was clearly effective than low-dose vaginal misoprostol, although some methods were less effective and safety ...

Core Scientific, Inc. (NASDAQ:CORZ) is one of the 15 software stocks with the highest upside potential. On January 6, investor commentary highlighted growing investor confidence around Core Scientific ...

Financial giants have made a conspicuous bullish move on Core Scientific. Our analysis of options history for Core Scientific (NASDAQ:CORZ) revealed 8 unusual trades. Delving into the details, we ...

Core Scientific, Inc. (NASDAQ:CORZ) is one of the AI Stocks on the Market’s Radar. On December 18, Citizens upgraded the stock from Market Perform to “Market Outperform” with a price target of $30.00.

Asset manager VR Advisory Services acquired more than 1.2 million CORZ shares in the third quarter, increasing its U.S. equity exposure by approximately $21.7 million. The transaction represents 5.3% ...

CoreWeave and Core Scientific climbed after hours as Nvidia’s strong Q3 earnings revived optimism in the AI trade. CoreWeave benefited from improved GPU demand, while Core Scientific gained as markets ...

Nvidia is the face of the AI revolution and its strong earnings report reassured investors that the AI trade is still alive and strong. Read Next: Nvidia Sell Signal? 3 Market Legends Dump The Stock ...

Oaktree added 6.4 million shares of Core Scientific for an estimated $114.8 million in the third quarter. The Core Scientific position represents 1.8% of Oaktree’s 13F reportable assets under ...

The most common technique used for closing the uterus after a cesarean delivery causes so many long-term complications that it's time to question its use. That's the conclusion reached by two ...

CoreWeave CEO Mike Intrator addressed delays at a third-party data center developer. CNBC's Jim Cramer noted delays at sites in Texas, Oklahoma and North Carolina tied to Core Scientific. CoreWeave ...